Aptose Biosciences, Inc. (APTO)
APTO has a market cap or net worth of $110.30 million. The enterprise value is $15.90 million.
APTO has 88.95 million shares outstanding. The number of shares has increased by 3.60% in one year.
|Shares Change (YoY)||+3.60%|
|Shares Change (QoQ)||+0.00%|
|Owned by Insiders (%)||5.55%|
|Owned by Institutions (%)||45.28%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 11.60, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -53.70%, which is considered low. The company has a ROIC of -389.00%.
|Return on Equity (ROE)||-53.70%|
|Return on Assets (ROA)||-50.10%|
|Return on Capital (ROIC)||-389.00%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.43M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -71.09% in the last 52 weeks. The beta is 1.12, so APTO's price volatility has been higher than the market average.
|52-Week Price Change||-71.09%|
|50-Day Moving Average||1.44|
|200-Day Moving Average||2.27|
|Average Volume (30 Days)||1,243,579|
Short Selling Information
|Short % of Shares Out||0.72%|
|Short % of Float||0.83%|
|Short Ratio (days to cover)||0.32|
|Earnings Per Share (EPS)||-$0.63|
The company has $95.10 million in cash and $700,000 in debt, giving a net cash position of $94.40 million or $1.06 per share.
|Cash & Cash Equivalents||95.10M|
|Net Cash Per Share||$1.06|
|Book Value Per Share||1.00|
In the last 12 months, operating cash flow was -$37.61 million and capital expenditures -$224,000, giving a free cash flow of -$37.84 million.
|Operating Cash Flow||-37.61M|
|Free Cash Flow||-37.84M|
|FCF Per Share||n/a|
Dividends & Yields
APTO does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The last stock split was on October 6, 2014. It was a reverse split with a ratio of 1:12.
|Last Split Date||Oct 6, 2014|